Shares of Presbia PLC (NASDAQ:LENS) have earned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
Brokers have set a 12-month consensus price objective of $10.00 for the company, according to Zacks. Zacks has also given Presbia an industry rank of 84 out of 255 based on the ratings given to related companies.
NASDAQ LENS remained flat at $$0.55 during trading on Friday. 15,324 shares of the company’s stock were exchanged, compared to its average volume of 104,244. Presbia has a 1 year low of $0.28 and a 1 year high of $5.50.
Presbia Company Profile
Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in South Korea, Australia, New Zealand, Italy, the Netherlands, Ireland, Canada, and Germany.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Presbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia and related companies with MarketBeat.com's FREE daily email newsletter.